EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How ligands modulate the gastric H,K-ATPase activity and its inhibition by tegoprazan

Nicole T Cerf, Gerardo Zerbetto de Palma, Natalya U Fedosova, Claudia V Filomatori, Rolando C Rossi, Santiago E Faraj, Mónica R Montes

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Nicole T Cerf und 6 weiteren Autor:innen. Beteiligte Einrichtung: Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Instituto de Química y Fisicoquímica Biológicas "…. Hauptthemen laut MEDLINE: H(+)-K(+)-Exchanging ATPase, Potassium, Proton Pump Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council on Science and Technology, Agencia Nacional de Promoción Científica y Tecnológica, Secretaria de Ciencia y Tecnología - Universidad Nacional de Córdoba.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The introduction of potassium-competitive acid blockers (P-CABs) has been a major innovation in gastric H,K-ATPase inhibition and many laboratories are actively engaged in the development of novel molecules within this class. This work investigates the interaction between H,K-ATPase and tegoprazan, a representative of the P-CABs group, in terms of K+ and H+ binding, through functional and structural analyses. First, by studying the H,K-ATPase activity, we found a model to describe the non-Michaelis-Menten kinetics through a "ping-pong" mechanism that explains a stoichiometry of 1 H+, 1 K+, and 1 ATP molecule, but also considering the influence of H+ on the ionization states of the protein. A kinetic evaluation of the inhibition of tegoprazan denotes the binding to two different intermediates states with apparent Kd (μM) 0.56 ± 0.04 and 2.70 ± 0.24 at pH 7.2. Molecular dynamics simulations revealed important changes in the interactions of tegoprazan with the transmembrane residues depending on whether the site contains K+ or not. This explains the decrease in affinity as a function of K+ concentration observed in the kinetic experiments. On the other hand, the structures predict that the protonation of tegoprazan is responsible for the change in its dihedral angle. The rotation of the benzimidazole ring allows the inhibitor to be positioned further into the luminal cavity, a situation compatible with the higher inhibition affinity of H,K-ATPase measured at low pH. Results presented herein will provide a basis for the rational design of novel P-CABs ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

H(+)-K(+)-Exchanging ATPasePotassiumProton Pump InhibitorsLigandsKineticsAnimalsMolecular Dynamics SimulationHydrogen-Ion Concentration

Stichwörter der Autor:innen

H,K-ATPaseP-CABsP-type ATPasegastric acidity treatmentinhibition mechanismkinetic modelstegoprazan

Substanzen

H(+)-K(+)-Exchanging ATPaseLigandsPotassiumProton Pump Inhibitors

Autor:innen und Institutionen

  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Instituto de Química y Fisicoquímica Biológicas "Prof. Alejandro C. Paladini" (IQUIFIB), Buenos Aires, Argentina.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Instituto de Química y Fisicoquímica Biológicas "Prof. Alejandro C. Paladini" (IQUIFIB), Buenos Aires, Argentina. Elect…

Förderung

  • National Council on Science and Technology
  • Agencia Nacional de Promoción Científica y Tecnológica
  • Secretaria de Ciencia y Tecnología - Universidad Nacional de Córdoba
  • Ministerio de Ciencia, Tecnología e Innovación
  • Fund for Scientific and Technological Research
  • Consejo Nacional de Investigaciones Científicas y Técnicas

Zitieren

APA

Cerf, N. T., Zerbetto de Palma, G., Fedosova, N. U., Filomatori, C. V., Rossi, R. C., Faraj, S. E., & Montes, M. R. (2024). How ligands modulate the gastric H,K-ATPase activity and its inhibition by tegoprazan. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107986

Vancouver

Cerf NT, Zerbetto de Palma G, Fedosova NU, Filomatori CV, Rossi RC, Faraj SE, et al. How ligands modulate the gastric H,K-ATPase activity and its inhibition by tegoprazan. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107986

BibTeX
@article{Cerf2024,
  author = {Cerf, Nicole T and Zerbetto de Palma, Gerardo and Fedosova, Natalya U and Filomatori, Claudia V and Rossi, Rolando C and Faraj, Santiago E and Montes, Mónica R},
  title = {How ligands modulate the gastric H,K-ATPase activity and its inhibition by tegoprazan},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107986}
}
Kostenlos starten →